Company intelligence / Profile preview

Access Biologicals

Vista, California, United States

Ownership: Private
Employees: ~90
Development stage: Other

Overview

Access Biologicals, now part of Grifols, is a leading commercial provider of high-quality human biological materials (blood, plasma, and related biospecimens) for research, diagnostics, and cell culture applications. The company is FDA, CLIA, and ISO certified. Its business model focuses on supplying biological source materials for downstream use and it does not directly lead drug development or clinical trial programs.

Industry: Chemicals & Materials

Partnerships

Grifols

Beyond the preview

Go deeper on Access Biologicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Access Biologicals.

Explore the full profile